Gao Li, Barnes Kathleen C
The Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224, USA.
Am J Physiol Lung Cell Mol Physiol. 2009 May;296(5):L713-25. doi: 10.1152/ajplung.90269.2008. Epub 2009 Feb 13.
It has been well established that acute lung injury (ALI), and the more severe presentation of acute respiratory distress syndrome (ARDS), constitute complex traits characterized by a multigenic and multifactorial etiology. Identification and validation of genetic variants contributing to disease susceptibility and severity has been hampered by the profound heterogeneity of the clinical phenotype and the role of environmental factors, which includes treatment, on outcome. The critical nature of ALI and ARDS, compounded by the impact of phenotypic heterogeneity, has rendered the amassing of sufficiently powered studies especially challenging. Nevertheless, progress has been made in the identification of genetic variants in select candidate genes, which has enhanced our understanding of the specific pathways involved in disease manifestation. Identification of novel candidate genes for which genetic association studies have confirmed a role in disease has been greatly aided by the powerful tool of high-throughput expression profiling. This article will review these studies to date, summarizing candidate genes associated with ALI and ARDS, acknowledging those that have been replicated in independent populations, with a special focus on the specific pathways for which candidate genes identified so far can be clustered.
急性肺损伤(ALI)以及更为严重的急性呼吸窘迫综合征(ARDS)已被充分证实是具有多基因和多因素病因特征的复杂性状。临床表型的高度异质性以及环境因素(包括治疗)对预后的作用,阻碍了对导致疾病易感性和严重程度的基因变异的识别与验证。ALI和ARDS的严重性,再加上表型异质性的影响,使得开展有足够样本量的研究极具挑战性。尽管如此,在选定的候选基因中识别基因变异方面已取得进展,这增进了我们对疾病表现所涉及的特定途径的理解。高通量表达谱分析这一强大工具极大地助力了新候选基因的识别,基因关联研究已证实这些新候选基因在疾病中发挥作用。本文将回顾迄今为止的这些研究,总结与ALI和ARDS相关的候选基因,认可那些在独立人群中得到重复验证的基因,特别关注目前已识别出的候选基因可归为的特定途径。